Warner Pharmaceuticals: Some of the company's medicines are scheduled for centralized procurement by national organizations, and the procurement of products with expired agreement periods will continue.

2026-02-27 04:08:48

Warner Pharmaceuticals Announcement: The company participated in the national organized procurement drug agreement renewal, and some drugs are expected to be selected. A total of 12 products are expected to be selected, with projected sales revenue of 176 million yuan in 2024, accounting for 12.47% of the company’s operating income in 2024; from January to September 2025, sales revenue is expected to be 192 million yuan, accounting for 17.69% of the company’s operating income in the same period. The procurement cycle is from the actual implementation date of the selection results until December 31, 2028.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes